Nemaura Medical (NMRD) Reports Positive Interim Data from Home-Use Portion of SugarBEAT Study
Tweet Send to a Friend
Nemaura Medical Inc. (NASDAQ: NMRD) today announced it has initiated the first of a number of planned studies in support ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
